Tatjana Rundek, M.D. Ph.D.
Associate Prof of Neurology (Tenure-earning track)
Department of Neurology
UNIVERSITY OF MIAMI
Curriculum Vitae
HIGHER EDUCATION
Institutional (institution; degree; date conferred):
University of Zagreb, College of Mathematics, Croatia
Medical School University of Zagreb, Croatia
Medical School University of Zagreb, Croatia
Ludwig-Maximillian University, Munich, Germany
B.S.
M.D.
M.S.
Ph..D.
1977-81
1981-86
1986-88
1990-95
Mathematics
Medicine
Biomedicine
Neuroscience
EXPERIENCE
Academic (institutions; rank/status; dates):
Medical School University of Zagreb, Croatia
Medical School University of Zagreb, Croatia
University of Ulm, Germany
Ludwig-Maximillian University, Munich, Germany
Ludwig-Maximillian University, Munich, Germany
Columbia University, New York, NY
Columbia University, New York, NY
University of Miami, Miami, FL
Assistant Professor
Associate Professor
Assistant Professor
Assistant Professor
Associate Professor
Assistant Professor
Adjunct Professor
Associate Professor
1993-94
1994-96
1995-96
1996-97
1997-98
2002-07
20072007-
Hospital Appointments (institutions, dates)
Medical Intern
University Hospital for Pulmonary Diseases,
Intensive Care Unit and Respiratory Care Center,
University of Zagreb, Croatia
Neurology Resident
Grossharden Spital Munich, Germany and
University Hospital Sestre Milosrdnice, Zagreb,
Croatia
Stroke Attending
University Hospital Sestre Milosrdnice, Zagreb,
Croatia
Stroke Fellow
University of Ulm, Germany
Director, Stroke Division
University Hospital Sestre Milosrdnice, Zagreb,
Croatia
Stroke Attending
Grossharden Spital Munich, Germany
Stroke Research Fellow
Columbia-Presbyterian Medical Center, NY
Columbia University, New York, NY
Director, Non-Invasive
Columbia-Presbyterian Medical Center, NY
Neurosonology Laboratory
Columbia University, New York, NY
Director, Clinical Translational Department of Neurology, University of Miami,
Research Division
Miami, FL
1986-87
1988-92
1992-95
1995-96
1995-96
1996-97
1998-200
0
2002-07
2007-
----------------------------------------------------------------------------------------------------------------------------- -------------------Tatjana Rundek, Curriculum Vitae_09
1 of 17
PUBLICATIONS
Original, Peer Reviewed Articles
1. Wang L, Beecham A, Di Tullio MR, Slifer S, Blanton SH, Rundek T, Sacco RL. Novel
Quantitative trait locus is mapped to chromosome 12p11 for left ventricular mass in Dominican families:
the Family Study of Stroke Risk and Carotid Atherosclerosis. BMC Med Genet. 2009;10(1): 74.
2. Dhamoon MS, Moon YP, Paik MC, Boden-Albala B, Rundek T, Sacco RL, Elkind MS. Long-Term
Functional Recovery After First Ischemic Stroke. The Northern Manhattan Study. Stroke. 2009; 40(8):
2805-11.
3. Russo C, Jin Z, Rundek T, Homma S, Sacco RL, Di Tullio MR.Atherosclerotic disease of the proximal
aorta and the risk of vascular events in a population-based cohort: the Aortic Plaques and Risk of Ischemic
Stroke (APRIS) study. Stroke. 2009;40(7):2313-8.
4. Sacco RL, Blanton SH, Slifer S, Beecham A, Glover K, Gardener H, Wang L, Sabala E, Juo SH, Rundek T.
Heritability and linkage analysis for carotid intima-media thickness: the family study of stroke risk and
carotid atherosclerosis.Stroke. 2009;40(7):2307-2312.
5. Takei Y, Di Tullio MR, Homma S, Boden-Albala B, Rundek T, Sacco RL, Berry G, Liu R, Jin Z, Eguchi K,
Elkind MS. Soluble tumor necrosis factor receptor 1 level is associated with left ventricular hypertrophy:
the northern Manhattan study. Am J Hypertens. 2009;22(7):763-9.
6. Kohsaka S, Jin Z, Rundek T, Boden-Albala B, Homma S, Sacco RL, Di Tullio MR. Impact of mitral
annular calcification on cardiovascular events in a multiethnic community: the Northern Manhattan Study.
JACC Cardiovasc Imaging. 2008;1(5):617-623.
7. Demarin V, Basić-Kes V, Zavoreo I, Bosnar-Puretić M, Rotim K, Lupret V, Perić M, Ivanec Z, Fumić L,
Lusić I, Aleksić-Shihabis A, Kovac B, Ivanković M, Skobić H, Maslov B, Bornstein N, Niederkorn K,
Sinanović O, Rundek T; Ad hoc Committee of the Croatian Society for Neurovascular Disorders; Croatian
Medical Association. Recommendations for neuropathic pain treatment. Acta Clin Croat. 2008;47(3):
181-191.
8. D'Ambrosio D, Della-Morte D, Gargiulo G, Rossetti M, Rundek T, Rengo F, Abete P.Intrapetrous internal
carotid artery dissection and essential thrombocythemia: what relationship? A case report. Cases J.
200827;1(1):354.
9. Ratchford EV, Jin Z, Tullio MR, Salameh MJ, Homma S, Gan R, Boden-Albala B, Sacco RL, Rundek T.
Carotid bruit for detection of hemodynamically significant carotid stenosis: the Northern Manhattan Study.
Neurol Res. 2009 Jan 7. [Epub ahead of print] PMID: 19133168]
10. Ratchford EV, Jin Z, Tullio MR, Salameh MJ, Homma S, Gan R, Boden-Albala B, Sacco RL, Rundek T.
Carotid bruit for detection of hemodynamically significant carotid stenosis: the Northern Manhattan Study.
Neurol Res. 2009 Jan 7. [Epub ahead of print] PMID: 19133168
11. Rundek T, Elkind MS, Di Tullio MR, Carrera E, Jin Z, Sacco RL, Homma S. Patent foramen ovale and
migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation. 2008;
118(14):1419-24. Epub 2008 Sep 15. Erratum in: Circulation. 2008 Oct 28;118(18):e682.
12. Kohsaka S, Jin Z, Rundek T, Boden-Albala B, Homma S, Sacco RL, Di Tullio MR. Impact of mitral
annular calcification on cardiovascular events in a multiethnic community: the Northern Manhattan Study.
JACC Cardiovasc Imaging. 2008;1(5):617-23.
13. D'Ambrosio D, Della-Morte D, Gargiulo G, Rossetti M, Rundek T, Rengo F, Abete P. Intrapetrous internal
carotid artery dissection and essential thrombocythemia: what relationship? Cases J. 2008; 27;1(1):354.
14. Liao YC, Lin HF, Rundek T, Cheng R, Guo YC, Sacco RL, Juo SH. Segment-specific genetic effects on
carotid intima-media thickness: the Northern Manhattan study. Stroke. 2008;39(12):3159-65.
15. Della Morte D, Abete P, Gallucci F, Scaglione A, D'Ambrosio D, Gargiulo G, De Rosa G, Dave KR, Lin
HW, Cacciatore F, Mazzella F, Uomo G, Rundek T, Perez-Pinzon MA, Rengo F. Transient ischemic
attack before nonlacunar ischemic stroke in the elderly. J Stroke Cerebrovasc Dis. 2008; 17(5):257-62.
16. Fillit H, Nash DT, Rundek T, Zuckerman A. Cardiovascular risk factors and dementia. Am J Geriatr
Pharmacother. 2008;6(2):100-18.
17. Suzuki T, Hirata K, Elkind MS, Jin Z, Rundek T, Miyake Y, Boden-Albala B, Di Tullio MR, Sacco R,
Homma S. Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern
----------------------------------------------------------------------------------------------------------------------------- -------------------Tatjana Rundek, Curriculum Vitae_09
2 of 17
Manhattan Study (NOMAS). Am Heart J. 2008 Aug;156(2):405-10.
18. Salameh MJ, Rundek T, Boden-Albala B, Jin Z, Ratchford EV, Di Tullio MR, Homma S, Sacco RL.
Self-reported peripheral arterial disease predicts future vascular events in a community-based cohort. J Gen
Intern Med. 2008 Sep;23(9):1423-8.
19. Eguchi K, Boden-Albala B, Jin Z, Rundek T, Sacco RL, Homma S, Di Tullio MR. Association between
diabetes mellitus and left ventricular hypertrophy in a multiethnic population. Am J Cardiol. 2008 Jun
15;101(12):1787-91.
20. Rundek T, Arif H, Boden-Albala B, Elkind MS, Paik MC, Sacco RL. Carotid artery plaque thickness
predicts ischemic stroke, myocardial infarction and vascular death: The Northern Manhattan Study.
Neurology 2008;70(14):1200-7.
21. Eguchi K, Boden-Albala B, Jin Z, Rundek T, Sacco RL, Homma S, Di Tullio MR. Association between
diabetes mellitus and left ventricular hypertrophy in a multiethnic population. Am J Cardiol.
2008;101(12):1787-91.
22. Liao Y-C, Lin H-F, Rundek T, Cheng R, His E , Sacco RL, Juo S-H. Multiple genetic determinants of
plasma lipid levels in Caribbean Hispanics. Clinical Biochemistry 2007; [Epub ahead of print] PMID:
18078817
23. Boden-Albala B, Sacco RL, Lee HS, Graham-Clarke C, Rundek T, Elkind MS, Giardinia EG, Di Tullio
MR, Homma S, Paik MC. Metabolic syndrome and risk of vascular events and ischemic stroke by gender
and race-ethnicity: The Northern Manhattan Study. Stroke 2008;39(1):30-35.
24. Rubin MR, Rundek T, McMahon DJ, Lee H-H, Sacco RL, Silverberg SJ. Carotid artery plaque thickness is
associated with increased serum calcium levels: the Northern Manhattan Study. Atherosclerosis
2007;194(2):426-432.
25. Eguchi K, Boden-Albala B, Jin Z, Di Tullio MR, Rundek T, Rodriguez CJ, Homma S, Sacco RL.
Usefulness of Fasting Blood Glucose to Predict Vascular Outcomes Among Individuals Without Diabetes
Mellitus (from the Northern Manhattan Study). Am J Cardiol 2007;100(9):1404-1409.
26. Sacco RL, Sabala EA, Rundek T, Juo S-H, Huang JS, Di Tullio MR, Homma S, Almonte K, Lithgow CG,
Boden-Albala B. Design of a family study among high-risk Caribbean Hispanics: the Northern Manhattan
Family Study. Ethn Dis. 2007;17(2):351-357.
27. T. Rundek, Brook RD, Spence JD. Carotid Plaque- Lost in translation:- Prediction of clinical
cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis.
Circulation. 2007; 28;116(9): e317.
28. Godia EC, Madhok R, Pittman J, Trocio S, Ramas R, Cabral D, Sacco RL, Rundek T. Carotid Artery
Distensibility. A Reliability Study. J Ultrasound Med 2007; 26:1157–1165.
29. Suzuki K, Juo S-H, Rundek T, Boden-Albala B, Disla N, Liu R, Park N, Di Tullio MR, Sacco RL, Homma
S. Genetic contribution to brachial artery flow-mediated dilation: The Northern Manhattan Family Study.
Atherosclerosis. 2007; PMID: 17462653
30. Prabhakaran S, Singh R, Zhou X, Ramas R, Sacco RL, Rundek T. Presence of calcified carotid plaque
predicts vascular events: The Northern Manhattan Study. Atherosclerosis. 2007; 195(1): e197-201
31. Dhamoon MS, Tai W, Boden-Albala B, Rundek T, Paik MC, Sacco RL, Elkind MS. Risk of myocardial
infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke.
2007;38(6):1752-1758.
32. Rundek T, H. White, Boden-Albala B, X. Luo, Elkind MS, Sacco RL. The metabolic syndrome and
subclinical carotid atherosclerosis: The Northern Manhattan Study. JCMS 2007, 2: 24-29.
33. Abe Y, Rundek T, Sciacca RR, Sacco RL, Homma S, Di Tullio MR. Cardiac and carotid ultrasonography
for risk stratification of coronary artery disease and stroke association with Framingham Heart and Stroke
Risk Score in the Northern Manhattan Study. Am J Cardiol 1006: 98:1374-1378.
34. Prabhakaran S, Rundek T, Ramas R, Elkind MS, Paik MC, Boden-Albala B, Sacco RL. Carotid plaque
surface irregularity predicts ischemic stroke.The Northern Manhattan Study. Stroke
2006;37(11):2696-2701.
35. Rundek T, Hundle R, Ratchford E, Ramas R, Sciacca RR, Di Tullio MR, Boden-Albala B, Elkind MS,
Sacco RL, Homma S. Endothelial dysfunction is associated with carotid plaque: A cross-sectional study
from the population based Northern Manhattan Study. BMC Cardiovasc Disord 2006;6(1):35-41.
36. Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D’Agostino RB, Detrano RC, Herrington
DM. Gender and hs-C-Reactive Protein: Data from the Multi-Ethnic Study of Atherosclerosis (MESA)
----------------------------------------------------------------------------------------------------------------------------- -------------------Tatjana Rundek, Curriculum Vitae_09
3 of 17
Cohort. AHJ 2006;152(3):593-598.
37. Hays AG, Sacco RL, Rundek T, Sciacca RR, Jin Z, Liu R, Homma S, Di Tullio MR. Left ventricular
systolic dysfunction and the risk of ischemic stroke in a multiethnic population. Stroke 2006;
37(7):1715-1719.
38. C.B.Wright, Elkind MS, Rundek T, Boden-Albala B, Paik MC, Sacco RL. Alcohol intake, carotid plaque,
and cognition: the Northern Manhattan Study. Stroke 2006;37(5):1160-1164.
39. M.S.Dhamoon, Sciacca RR, Rundek T, Sacco RL, Elkind MS. Recurrent stroke and cardiac risks after first
ischemic stroke: the Northern Manhattan Study. Neurology 2006;66(5):641-646.
40. C.B.Wright, Sacco RL, Rundek T, Delman JB, Rabbani LE, Elkind MS. Interleukin-6 is associated with
cognitive function: the Northern Manhattan Study. J Stroke Cerebrovasc Dis 2006;15(1):34-38.
41. Frontera JA, Rundek T, Schmidt JM, Claassen J, Parra A,.Wartenberg KE, Temes RE, Mayer SA, Mohr JP,
Marshall RS. Cerebrovascular reactivity and vasospasm after subarachnoid hemorrhage: a pilot study.
Neurology 2006;66(5):727-729.
42. Elkind MS, Sciacca RR, Boden-Albala B, Rundek T, Paik MC, Sacco RL. Moderate alcohol consumption
reduces risk of ischemic stroke: The Northern Manhattan Study. Stroke 2006;37:13-19.
43. Juo S-H, Rundek T, Lin HF, Cheng R, Lan MY, Huang JS, Boden-Albala B, Sacco RL. Heritability of
carotid artery distensibility in Hispanics: the Northern Manhattan Family Study. Stroke
2005;36(11):2357-2361.
44. Juo S-H, Di Tullio MR, Lin HF, Rundek T, Boden-Albala B, Homma S, Sacco RL. Heritability of left
ventricular mass and other morphologic variables in Caribbean Hispanic subjects: the Northern Manhattan
Family Study. J Am Coll Cardiol 2005;46(4):735-737.
45. Lin HF, Boden-Albala B, Juo S-H, Park N, Rundek T, Sacco RL. Heritabilities of the metabolic syndrome
and its components in the Northern Manhattan Family Study. Diabetologia 2005; 18(3):282-286.
46. Elkind MS, Sciacca RR, Boden-Albala B, Rundek T, Paik MC, Sacco RL. Relative elevation in baseline
leukocyte count predicts first cerebral infarction. Neurology 2005;64(12):2121-2125.
47. Boden-Albala B, Litwak E, Elkind MS, Rundek T, Sacco RL. Social isolation and outcomes post stroke.
Neurology 2005;64(11):1888-1892.
48. Elkind MS, Rundek T, Sciacca RR, Ramas R, Chen HJ, Boden-Albala B, Rabbani L, Sacco RL.
Interleukin-2 levels are associated with carotid artery intima-media thickness. Atherosclerosis
2005;180(1):181-187.
49. White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, Sacco RL. Ischemic stroke
subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 2005;
15;111(10): 1327-1331.
50. Desvarieux M, Demmer RT, Rundek T, Boden-Albala B, Jacobs DR Jr, Sacco RL, Papapanou PN.
Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease
Epidemiology Study (INVEST). Circulation 2005;111(5):576-582.
51. Engebretson SP, I.B.Lamster, Elkind MS, Rundek T, Serman NJ, Demmer RT, Sacco RL, Papapanou PN,
Desvarieux M. Radiographic measures of chronic periodontitis and carotid artery plaque. Stroke
2005;36(3):561-566.
52. Elkind MS, Cheng J, Rundek T, Boden-Albala B, Sacco RL. Leukocyte count predicts outcome after
ischemic stroke: The Northern Manhattan Stroke Study. J Stroke Cerebrovasc Dis. 2004;13(5):220-227.
53. Juo S-H, Lin HF, Rundek T, Sabala EA, Boden-Albala B, Park N, Lan MY, Sacco RL. Genetic and
environmental contributions to carotid intima-media thickness and obesity phenotypes in the Northern
Manhattan Family Study. Stroke 2004;35(10):2243-2247.
54. Rundek T, Naini A, Sacco RL, Coates K, DiMauro S. Atorvastatin decreases the coenzyme Q10 level in
the blood of patients at risk for cardiovascular disease and stroke. Arch Neurol 2004; 61:889-892.
55. Rundek T, Nielsen K, Phillips S, Johnston KC, Hux M, Watson D; for the GAIN Americas Investigators.
Health care resource use after acute stroke in the Glycine Antagonist in Neuroprotection (GAIN) Americas
Trial. Stroke 2004; 35(6):1368-1374
56. Desvarieux M, Demmer RT, Rundek T, Boden-Albala B, Jacobs DR Jr, Papapanou PN, Sacco RL.
Relationship between periodontal disease, tooth loss, and carotid artery plaque. The Oral Infections and
Vascular Disease Epidemiology Study (INVEST). Stroke 2003;34(9):2120-2125.
57. McFarlane SI, Shin JJ, Rundek T, Bigger JT. Prevention of Type 2 Diabetes. Current Diabetes Reports
2003; 3(4):235–241.
----------------------------------------------------------------------------------------------------------------------------- -------------------Tatjana Rundek, Curriculum Vitae_09
4 of 17
58. Marshall RS RS, Rundek T, Sproule DM, Fitzsimmons BF, Schwartz S, Lazar RM. Monitoring of cerebral
vasodilatory capacity with transcranial Doppler carbon dioxide inhalation in patients with severe carotid
artery disease. Stroke 2003;34(4):945-949.
59. Rundek T, Elkind MS, Pittman J, Boden-Albala B, Martin S, Humphries SE, Juo S-H, Sacco RL. Carotid
Intima-Media Thickness is associated with Allelic Variants of Stromelysin-1, Interleukin-6 and Hepatic
Lipase Genes: The Northern Manhattan Prospective Cohort Study. Stroke 2002;333(5): 1420-1423.
60. Marshall RS, Lazar RM, Young WL, Solomon RA, Joshi S, Duong DH, Rundek T, Pile-Spellman J.
Clinical Utility of Quantitative Cerebral Blood Flow Measurements during Internal Carotid Artery Test
Occlusions. Neurosurgery 2002;50(5):996-1005.
61. Elkind MS, Cheng J, Boden-Albala B, Rundek T, Thomas J, Chen H, Rabbani LE, Sacco RL. Tumor
necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke 2002; 33(1):31-38.
62. Kalanj-Bognar S, Rundek T, Furac I, Demarin V, Cosovic C. Leukocyte lysosomal enzymes in
Alzheimer's disease and Down's syndrome. J Gerontol A Biol Sci Med Sci 2002; 57(1):B16-21.
63. Hartmann A, Rundek T, Mast H, Paik MC, Boden-Albala B, Mohr JP, Sacco RL. Mortality and causes of
death after first ischemic stroke: The Northern Manhattan Stroke Study. Neurology 2001; 57 (11):
2000-2005.
64. Sacco RL, DeRosa JT, Haley C, Levin B, Ordronneau P, Phillips SJ, Rundek T, Snipes RG, Thompson JLp.
Glycine antagonist in neuroprotection for patients with acute stroke. GAIN Americas: A randomized trial.
JAMA 2001;285:1719-1728
65. Rundek T, Mast H, Hartmann A, Boden-Albala B, Lennihan L, Lin I-Feng, Paik MC, Sacco RL. Predictors
of resource utilization after acute hospitalization: Northern Manhattan Stroke Study. Neurology 2000; 55:
1180-1187.
66. Rundek T, Di Tullio MR, Sciacca RR, Titova IV, Mohr JP, Homma S, Sacco RL. Association between
large arch atheromas and cerebral microemboli in elderly stroke patients. Stroke 1999;30:2683-2686.
67. Steiner MM, Di Tullio MR, Rundek T, Gan R, Chen X, Liguori C, Brainin M, Homma S, Sacco RL. Patent
foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 1998;
29 (3): 944-948.
68. Lovrencic-Huzjan A, Demarin V, Vukovic V, Rundek T. Role of vertebral artery hypoplasia in migraine.
Cephalalgia 1998; 18(10): 684-686.
69. Rundek T, Demarin V Niederkorn N, Vukovic V, Podobnik S, Huzjan A, Starcevic B, Richter D, Planinc
D. Prevalencia de senales de embolia intracraneal en pacientes con patoligias carotideas o cardiacas.
Annales De Cirugia Cardiaca Y Cirugia Vascular 1998; 4(1):5-12.
70. Demarin V, Rundek T, Hodek B. Maternal circulation in normal and abnormal pregnancies. Acta Obstet
Gynecol Scand 1997; 76:619-624.
71. Ivekovic R, Rundek T, Mandic Z. Color Doppler imaging of the eye and orbit. SOE’97 Monduzzi editore.
Interantional Proceeding Division 1997; 1:589-592.
72. Demarin V, Rundek T. Cerebral henodynamic changes and the 5-HT (hydroxytriptamine) level in
migraine. Monduzzi Editore. International Proceedings Division 1997;1:25-28.
73. Rundek T, Huzjan-Lovrencic A, Runjic D, Demarin V. Evaluation of tandem lesions in patients with
bilateral carotid artery disease. Period Biol 1996, 98:1, 89-94.
74. Demarin V, Rundek T, Podobnik-Sarkanji S, Huzjan-Lovrencic A, D.Runjic. Detection of cerebral emboli
signals in patients with carotid stenosis and cardiac disease. Period Biol 1996; 98:1, 83-88.
75. Demarin V, Rundek T. Evaluation of maternal cerebral circulation by Transcranial Doppler in normal and
abnormal pregnancies, Acta Clin Croat 1996; 35:3-7.
76. Rundek T, Demarin V K.Niederkorn, Vukovic V, Podobnik S Sarkanji, D.Runjic, Huzjan-Lovrencic A
Lovrencic, B.Starcevic, D.Richter, D.Planinc. Prevalence of intracranial emboli signals in patients with
carotid and cardiac disease. Acta Clin Croat 1995; 34:3, 137-143.
77. Podobnik S Sarkanji, Demarin V, Rundek T, Huzjan-Lovrencic A Lovrencic. Risk factors for carotid
artery atherosclerosis. Acta Clin Croat 1995; 34:3, 145-157.
78. Rundek T, Huzjan-Lovrencic A-Huzjan Demarin V. Transcranial Doppler evaluation of tandem lesions in
patients with extracranial carotid artery disease. Acta Clin Croat 1994; 33: 25-35.
79. Rundek T, Demarin V. Cerebral vasoreactive response (CVR) in patients with multi-infarct dementia
(MID), dementia of Alzheimer’s type (DAT) and dementia in Parkinson’s disease (PDP). Proceedings of
the International Symposium on Dementia in Parkinson’s disease, Monduzzi Editore 1995; 119-123.
----------------------------------------------------------------------------------------------------------------------------- -------------------Tatjana Rundek, Curriculum Vitae_09
5 of 17
80. Demarin V, Rundek T, Podobnik-Sarkanji S, Huzjan-Lovrencic A. A correlation between
5-hydroxitriptamine and cerebral vasoreactivity in patients with migraine. Funct Neurol 1994; 9: 235-245.
81. Rundek T, Demarin V, Kittner B. Impairement of cerebral vasoreactivity (CVR) in patients with
multi-infarct dementia (MID). Acta Clin Croat 1993; 32: 51-59.
82. Podobnik-Sarkanji S, Rundek T, Demarin V, Kalousek M, Martinic I. Correlation between Computerized
Tomography and Transcranial Doppler Sonography in Patients with Speech Disorders. Acta Clin Croat
1993; 32:121-127.
83. Podobnik-Sarkanji S, Demarin V, Thaller N, Rundek T, Martinic I. Paratrigeminal syndrome. Neurol
Croat 1993; 42:161-167.
84. Rundek T, Demarin V, Despot I, De Syo D, Podobnik-Sarkanji S. Value of cerebral vasoreactivity testing
in patients with carotid artery disease before and after carotid endarcterectomy. Acta Clin Croat 1993; 32:
141-150.
85. Demarin V, Rundek T, Despot I, Podobnik-Sarkanji S, Thaller N. Importancia de la evalucion de la
capacidad vasoreactiva cerebral en la indicacion de la endarterectomia carotidea. Angiologia 1993; 95:
10-15.
86. Demarin V, Rundek T, Podobnik-Sarkanji S, Lukinac Lj, Music Z. Correlation between cerebral
vasoreactivity and plasma 5-HT level in migraine, Stroke 1993; 24: 515-516.
87. Podobnik-Sarkanji S, Demarin V, Rundek T, Martinic I. Transcranial Doppler assessment performed at
rest and during mental activities in patients with postconcussion syndrome. Period Biol
1993;95(4):423-428.
88. Demarin V, Rundek T, Thaller N, Podobnik-Sarkanji S. Cerebral vasoreactivity in ischemic stroke. Acta
Clin Croat 1992;31: 3-11.
89. Demarin V, Rundek T. Doppler (TCD): A simple non-invasive test for the assessment of cerebrl
vasoreactivity in humans. Periodicum Biol 1992; 94(3): 193-200.
90. Podobnik-Sarkanji S, Demarin V, Seric V, Rundek T, Martinic I. Transcranial Doppler assessment
performed on patients with postconssional syndrome. Acta Clin Croat 1992; 31: 255-260.
91. Demarin V, Podobnik-Sarkanji S, Huzjan-Lovrencic A, Rundek T, Thaller N. Stress as a risk factor for
neurological disorders: A study of refugees and solders of Croatian Army hospitalized in Neurology
Department of Clinical Hospital “Sestre milosrdnice”, Zagreb, Croatia, from 1990-1992. Acta Clin Croat
1992; 31: 233-238.
92. Demarin V, Rundek T, Tomljanovic B, Carillo-Pintos J, Masso-Estrade J. Prevention of Stroke - A report
form collaboration project between Zagreb and Barcelona. Neurol Croat 1992;41(1-2): 43-50.
93. Podobnik-Sarkanji S, Demarin V, Rundek T, Futac M. Development of carotid stenosis. Neurol Croat
1991;40(4): 283-291.
94. Rundek T, Demarin V, Lovrencic M, Vargek-Solter V, J.Carillo Pintos. Transcranial Doppler diagnostic
criteria in the evaluation of arteriovenous malformation. Neurol Croat 1991;40(4):259-267.
95. Demarin V, Blazic-Cop N, Dordevic V, Bosnjak M, Rundek T, Posavec V. Transcranial Doppler
investigation in cigarette smokers. Arteres et Veines 1991;10(2): 113-119.
96. Blazic-Cop N, Demarin V, Dordevic V, Rundek T, Bosnjak M. Extracranial carotid artery changes in
smokers investigated by duplex ultrasound. Arteres et Veines 1991;10(2): 120-124.
97. Dabic-Jeftic M, Dakic-Koretic D, Huzjan-Lovrencic A, Rundek T, Mikula I. Even related potentials
(P300) and Transcranial Doppler sonography in major depression. Psychiatria Danubina 1991; 3(1-2):
137-156.
98. Rundek T, Demarin V. Impairment of cerebral vasoreactivity in patients with multi-infarct dementia.
Biolog Psych 1991; 31:34-48.
Books and monographs published:
1. Rundek T. Carotid Ultrasound. In “Head and Neck Ultrasonography”. Editor: Lisa A. Orloff; Taylor &
Francis Group of London, New York, Philadelphia, Singapore and Sydney 2007; 122-145, 2008
2. Rundek T. Chapters: Ultrasonographic Atherosclerotic Plaque Morphology; TCD Monitoring of
Asymptomatic Embolization. In “Risk Stratification and Management of Patients with Asymptomatic
----------------------------------------------------------------------------------------------------------------------------- -------------------Tatjana Rundek, Curriculum Vitae_09
6 of 17
3.
4.
5.
6.
7.
8.
9.
10.
Carotid Artery Disease”. Editors: I. Mousa, Rundek T, J.P. Mohr; Taylor & Francis Group of London,
New York, Philadelphia, Singapore and Sydney 140-177, 2006.
Rundek T, Sacco RL. Outcome following stroke. In “Stroke- Pathophysiology, Diagnosis, and
Management”. Editors: J.P. Mohr, D.W. Choi, J.C. Grotta, B. Weir, P.A. Wolf; Fourth edition, Churchill
Livingstone, Elsevier Inc.; Chapter 3: 35-57, 2004.
Rundek T, Sacco RL. Outcome following stroke. In “Stroke- Pathophysiology, Diagnosis, and
Management”. Editors: J.P. Mohr, D.W. Choi, J.C. Grotta, B. Weir, P.A. Wolf; Fourth edition, Churchill
Livingstone, Elsevier Inc; Chapter 3: 35-57, 2004.
Rundek T. Chapters: Dementia; Metabolic Diseases and Neurological Disorders. In “Manual of
Neurology”. Editor: Demarin V; SK, Zagreb, Croatia, 72-97, 1998.
Rundek T, Demarin V Vukovic V, Podobnik S B.Starcevic. TCD detection of cerebral emboli in patients
with nonvalvular atrial fibrillation: A 1-year follow-up survey. In “New Trends in Cerebral Hemodynamics
and Neurosonology”. Editors: J.Klingelhofer, E. Bartels and E.B. Ringelstein; Elsevier: 435-440, 1997.
Rundek T. Chapters: Cerebral autoregulation, Vascular dementia, Therapeutic nihilism in treatment of
cerebrovascular diseases, Biochemistry of cerebral ischemia and therapeutic implications. In “Cerebral
circulation-clinical approach”. Editor: Demarin V, Naprijed, Zagreb, Croatia, 34-57, 1994.
Demarin V, Rundek T, Podobnik-Sarkanji S, Martinic I, Lukinac Lj, Kusic Z: Correlation between
Transcranial Doppler findings and biochemical parameters in patients with migraine. In "New Advances in
Headache Research". Editor: T. John; London, Smith-Gordon Eldred and Company Limited, 82-87, 1993.
Rundek T. SOS for non-smokers. Editors: Dordevic V, Blazic-Cop N; Global, Zagreb, 22-47, 1991.
Demarin V, Rundek T: The assessment of cerebral autoregulatory capacity (CAC) in ischemic
hemodynamic stroke. In "Recent Advances in Neurosonology“. Editors: M. Oka, G.M.Von Reutern, H.
Furuhata, K. Kodaira; Amsterdam, 277-280, 1992.
Juried or refereed journal articles or exhibitions:
Editorials
1. Rundek T, Sacco RL. Risk factor management to prevent first stroke. Neurol Clin. 2008; 26(4): 1007-45.
2. Rundek T. PFO in stroke: a direct association or coincidence? Eur J Neurol. 2008;15(9):887-8.
3. Rundek T. Beyond percent stenosis: carotid plaque surface irregularity and risk of stroke. International J
Stroke. 2007; 2 (3): 169-171.
4. Rundek T. Do Women Have Worse Outcome After Stroke Caused by Intracranial Arterial Stenosis?
Stroke. 2007;38(7):2025-2027.
5. T. Rundek, Bennett DA. Cognitive leisure activities, but not watching TV, for future brain benefits.
Neurology 2006; 66(6): 794-795.
6. Rundek T. Are young people with elevated carotid-intima media thickness at increased risk of vascular
events? Nature. Clinical Practice Point Neurology 2006; 2(7):362-363.
7. McFarlane SI, Rundek T, Nicasio J, Deshmukh M, Sowers JR. The DREAM Trial and the prospect of
Diabetes Prevention. Current Diabetes Report 2006, 3(6):205-206.
8. Rundek T, Sacco RL, Demarin V. Neuroprotection in Acute Stroke: Is there still hope? Acta Clin Croat.
2002;41:45-49.
9. Rundek T, Sacco RL. Acute ischemic stroke: An acute aggressive treatment. Acta Clin Croat 1998;
37:34-42.
Other works, publications and abstracts:
Press releases or web articles
1. NOMAS: Just a 2% Overlap for PFO and Migraine; St Jude Shuts Down ESCAPE Trial, Heartwire,
http://www.medscape.com/viewarticle/581840_print
----------------------------------------------------------------------------------------------------------------------------- -------------------Tatjana Rundek, Curriculum Vitae_09
7 of 17
2. Even minor plaque build-up in artery quadruples stroke, heart attack risk, Thaindian news, March 20th,
2008 - 1:50 pm ICT, http://www.thaindian.com/n
3. Hispanics With Artery Buildup Have Greater Risk Of Vascular Events Than Blacks, Whites, Study Finds,
Medical News Today, Cardiovascular / Cardiology News 21 Mar 2008 - 5:00 PDT,
http://www.medicalnewstoday.com/articles/101275.php
4. Artery Plaque Boosts Hispanics' Odds for Stroke, Even a small amount in neck artery quadrupled the risk,
study found, US News Report, http://health.usnews.com/usnews/health
5. Metabolic syndrome doubles stroke risk. CNN, February 7, 2004 Posted: 9:38 AM EST
6. Metabolic syndrome may be an important link to stroke. Neurology Reviews, April 2004;12:4
7. Atorvastatin lowers coQ10 levels in patients at risk of cardiovascular disease. Life Exstension- What’s Hot,
June 23, 2004 (http://lef.org/whatshot)
8. ANA: Elevated serum calcium linked to increased carotid-artery plaque thickness. San Francisco, Ca,
November 4, 2003 (www.pslgroup.com/dg/23dad2.htm)
Abstracts
1. Rundek T, Elkind MS, Di Tullio MR, Carrera E, Jin Z, Sacco RL, Homma S. Patent Foramen Ovale and
Migraine. A Cross-Sectional Study from the Northern Manhattan Study (NOMAS). Circulation 2007 , 116
(16): 3615.
2. Kohsaka S, Sacco RL, Jin Z, Liu R, Rundek T, Boden-Albala B, Homma S. Di Tullio MR. Thickness of
Mitral Annular Calcification is Directly Associated with Cardiovascular Morbidity and Mortality. The
Northern Manhattan Study. Circulation 2007, 116(16): 3577.
3. Kohsaka S, Sacco RL, Jin Z, Russo C, Rundek T, Boden-Albala B, S Homma, Di Tullio MR. Comparison
of lipid parameters for detection of atherosclerotic burden in the proximal thoracic aorta. Circulation
2007116 (16): 2996.
4. Kohsaka S, Sacco RL, Jin Z, Liu R, Rundek T, Boden-Albala B, S Homma, Di Tullio MR. Race-ethnic
differences in the association between mitral annual calcification and CVD. The Northern Manhattan
Study. Circulation. Circulation 2007116 (16): 3501.
5. Choi JH, Rundek T, Marshall RS, Mast H, Mohr JP, Pile-Spellman J. Cold saline infusion into the carotid
artery decreases ipsilateral middle cerebral artery blood flow. Cerebrovasc Dis 2007; 23:57
6. Carrera E, Birnbaum L, Ramas R, Cabral D, Boden-Albala B, Sacco RL, Rundek T. Carotid IMT and
small non-stenotic carotid plaque have a different predictive value of fatal and non-fatal stroke and MI in a
multi-ethnic cohort. Cerebrovasc Dis 2007; 23:46.
7. Rundek T, Crutchfield KE, Ramas R, Sacco RL. Carotid IMT and Dynamic Vascular Analysis (DVA): A
Comprehensive Analysis of the Vessel Structure and Function. Cerebrovasc Dis 2006:37.
8. Salameh M, Rundek T, Jacoby D, Jin Z, Ratchford E, Boden-Albala B, Homma S, Sacco RL.
Self-Reported peripheral arterial disease predicts risk of combined vascular events beyond the Framingham
risk score in the Northern Manhattan Study. JACC 2006; 911-188:294.
9. Abe Y, Rundek T, Sciacca RR, Jin Z, Sacco RL, Homma S, Di Tullio MR. Stratification of coronary risk
beyond the Framingham risk classification: Ultrasound assessment of subclinical disease in multiethnic
population. JACC 2006; 983-208:338A.
10. Rundek T, Tessitore E, R.Sciacca, Sacco RL, Homma S, Di Tullio MR. Association between carotid
Intima-media thickness and aortic arch plaque thickness in the elderly. JACC 2006;980-188:334A.
11. Prabhakaran S, Rundek T, Luo X, Singh R, Gervasi-Franklin P, Ramas R, Sacco RL. Carotid Plaque
Surface Irregularity Predicts Ischemic Stroke: The Northern Manhattan Study, International Stroke
Conference, Stroke 2006;377.
12. Singh R, Zhou X, Prabhakaran S, Cespedes S, Ramas R, Sacco RL, Rundek T. Carotid plaque calcification
predicts incident stroke, myocardial infarction and vascular death in the Northern Manhattan Study. Stroke
2006;
13. Rundek T, Elkind MS, Sacco RL. The short-term effect of atorvastatin on carotid artery wall
elasticity:B-mode ultrasound distensibility study. J Ultrasound Med 2005, 24:S54-S55.
14. Rundek T, Boden-Albala B, Lou X, Ramas R, Saniel J, Sacco RL. Carotid artery plaque and carotid IMT:
Different stages or different phenotypes of subclinical atherosclerosis? Cerebrovasc Dis 2005, 19(1): 1-56,
----------------------------------------------------------------------------------------------------------------------------- -------------------Tatjana Rundek, Curriculum Vitae_09
8 of 17
15-43.
15. Crutcfield KE, Huang S, Ramas R, Sacco RL, Rundek T. Carotid IMT and dimanyc vascular analysis
(DVA): A comprehensive analysis of the vessel structure and function. Cerebrovasc Dis 2005, 19(1): 1-56,
8-22.
16. Rundek T , Sia RM, Marshall RS, Sacco RL, Mohr JP. Relationship Between Middle Cerebral Artery Flow
Velocity and Common Carotid Artery Flow Velocity, Volume Flow and Diameter During CO2 Inhalation.
Cerebrovasc Dis, 2004; 13(suppl 4):1-53:O50.
17. Rundek T, Lee H-S, Ramas R, Boden-Albala B, Godoy L, Szumski A, Coates K, Sacco RL. Metbolic
syndrome and carotid artery stiffness: A surrogate marker of atherosclerosis in the Northern Manhattan
Study. Stroke, 2004; 1(35):315-p322.
18. Khaw AV, Rundek T , Lee H-S, Stapf C, Schumacher CH, Mast H, Mohr JP, Sacco RL. Posterior
circulation ischemic stroke: Etiological differences from carotid artery territory infarction in the Northern
Manhattan Stroke Study. Stroke, 2004; 1(35):317-p332.
19. Khaw AV, Rundek T , Lee H-S , Stapf C, Schumacher HC, Mast H, Mohr JP, Sacco RL. More favorable
outcome after posterior circulation ischemic stroke than carotid artery territory: The Northern Manhattan
Stroke Study. Stroke, 2004; 1(35):317, p333.
20. Hays AG, Sacco RL, Sciacca RR, Rundek T, Liu R, Homma S, Di Tullio MR. Relationship between left
ventricular dysfunction and ischemic stroke subtype. Stroke, 2004; 1(35):313-p311.
21. Boden-Albala B, Lee H-S, Rundek T, Pike MC, Sacco RL. Race ethnicity, stroke risk and the metabolic
syndrome: Findings from the Northern Manhattan Study (NOMAS). Stroke, 2004; 1(35):243-245.
22. Liberatto B, Chong J, Lee H-S, Trocio S, Ramos O, Rundek T, Mohr JP, Sacco RL. Degree of carotid
stenosis and patient eligibility for intervention: The Northern Manhattan Stroke Study. Neurology, 2004;
62 (Sup 5): p02.081.
23. Demmer R, T. Rundek, Boden-Albala B, Elkind MS, Papapanou PN, Jacobs D, Jr., Sacco RL, Desvarieux
M. Periodontal disease and the presence of carotid artery plaque (CAP) in the multi-ethnic population of
Northern Manhattan: The oral INfections and Vascular disease Epidemiology STudy (INVEST). IADR
2004; 0236.
24. Rundek T, Lee H-S, Rubin MR, Silverberg SJ, Sacco RL. Serum Calcium is associated with carotid
plaque thickness: The Northern Manhattan Study. Annals of Neurology, 2003 (54), S7: S23-24.
25. Rundek T, Miyake Y, Sciacca RR, Di Tullio MR, Elkind MS, Boden-Albala B, Sacco RL, Homma S.
Brachial endothelial function is associated with subclinical carotid atherosclerosis: The Northern
Manhattan Study. Circulation. 2003; Vol. 108:18 (Supp IV): 2402.
26. Rodriguez CJ, Sciacca RR, Di Tullio MR, Elkind MS, Boden-Albala B, Grahame-Clark C, Rundek T,
Elkind MS, Sacco RL, Homma S. Impaired glucose tolerance is associated with endothelial dysfunction.
Circulation. 2003; Vol. 108:18 (Supp IV): 2405.
27. Di Tullio MR, Trifa D, Rundek T, Sciacca RR, Titova IV, Sacco RL, Homma S. Aortic plaques,
hypercoagulability and ischemic stroke. Circulation. 2003; Vol. 108:18 (Supp IV): 2741.
28. Rundek T, Giardina EC, Boden-Albala B, Lee H-S, Elkind MS, Sacco RL. Metabolic syndrome and
subclinical carotid atherosclerosis: The Northern Manhattan Study. International Symposium on
Triglycerides, Metabolic Disorders, and Cardiovascular Disease. New York, NY; July 10-13, 2003,
Abstract book: p.11.
29. Boden-Albala B, Lee H-S, Rundek T, Giardina EC, Elkind MS, MC. Paik, Sacco RL. Stroke risk and
metabolic syndrome. International Symposium on Triglycerides, Metabolic Disorders, and Cardiovascular
Disease. New York, NY; July 10-13, 2003, Abstract book: p.10.
30. Schumacher HC, Khaw AV, Rundek T, Khandji AG, Mohr JP, Sacco RL. Neuroradiological workup in
patients with a first-ever intracerebral hemorrhage - the Northern Manhattan Stroke. Neurology 2003;60(5),
Supp.1: A165.
31. Boden-Albala B, Lee H-S, Pike MC, Giardina E, Rundek T, Sacco RL. Stroke risk and the metabolic
syndrome: Findings from the Northern Manhattan Study. Neurology 2003;60(5), Supp.1: A255.
32. Rundek T, Sciacca RR, Perez-Apaga N, Juo S-H , Wright CB, Elkind MS, Boden-Albala B, Rodriguez CJ,
Di Tullio MR, S., Sacco RL. Apolipoprotein E (APOE) Polymorphism and Carotid Atherosclerosis: The
Northern Manhattan Study. Stroke 2003;34(1):291,P190.
33. Rosengart, Rundek T, Boden-Albala B, Lee H-S, Sacco RL. Dietary Fish Intake and the Risk of Ischemic
Stroke: The Northern Manhattan Study. Stoke 2003; 34(1):292, P197.
----------------------------------------------------------------------------------------------------------------------------- -------------------Tatjana Rundek, Curriculum Vitae_09
9 of 17
34. Marshall RS, Meyer SM, Connolly ES, Mohr JP, Lazar RM, Rundek T. Delayed Return of
Cerebrovascular Reactivity after Endarterectomy or Angioplasty. Stroke 2003; 34(1): 271, P78.
35. Wright CB, Rundek T, Huang S, Lee H-S, Boden-Albala B, Sacco RL. Homocysteine Is Associated with
Cognitive Impairment: The Northern Manhattan Study (NOMAS). Stroke 2003; 34(1):293, P202.
36. Elkind MS, Sciacca RR, Rundek T, Boden-Albala B, Sacco RL. Leukocyte Count Predicts Risk of
Ischemic Stroke: The Northern Manhattan Study. Stroke 2003; 34(1): 294, P210.
37. Elkind MS, Sciacca RR, Boden-Albala B, Sacco RL, Rundek T. Interleukin-2 Levels Are Associated with
Carotid Artery Intima-Media Thickness: The Northern Manhattan Study. Stroke 2003; 34(1): 295,P211.
38. Rundek T, Ramas R, Pittman J, Elkind MS, Boden-Albala B, Sacco RL. Carotid distensibility as a marker
of subclinical atherosclerosis: The Northern Manhattan Cohort Study, Cerebrovasc Dis 2002; 13(suppl
4):1-53:O50.
39. Desvarieux M, Demmer RT, Rundek T, Boden-Albala B, Elkind MS, Papapanou PN, Jacobs DR, Sacco
RL. The presence of carotid artery plaque (CAP) in patients with short and long-term periodontitis in the
multi-ethnic population of northern Manhattan: The Oral Infections and Vascular Disease Epidemiology
Study (INVEST). EPI Asia Pacific. 2002; p323.
40. Rundek T, Elkind MS, Pittman J, Wright CB, Boden-Albala B, Kaplan ED, Sacco RL. Carotid Artery
Plaque Thickness Predicts Ischemic Stroke, Myocardial Infarction and Vascular Death: The Northern
Manhattan Prospective Cohort Study. Neurology 2002;58(7), Supp.3: A118.
41. Suk S-H, Boden-Albala B, Pittman J, Rundek T, Elkind MS, Sacco RL. Obesity as a Stroke Risk Factor:
Waist Hip Ratio and Body Mass Index in the Northern Manhattan Stroke Study. Neurology 2002;58(7),
Supp.3: A114.
42. Wright CB, Rundek T, Pittman J, Boden-Albala B, Kaplan ED, Sacco RL. A Cross-Sectional Analysis of
Vascular Risk Factors and Cognitive Status in a Multiethnic Elderly Population. Neurology 2002;58(7),
Supp.3: A113.
43. Schumacher HC, Rundek T, Boden-Albala B, Mohr JP, Sacco RL. Predictors of Needing Help for Basic
ADL Functions at 6 Months Following Acute Ischemic Stroke: The Northern Manhattan Stroke. Neurology
2002;58(7), Supp.3: A325.
44. Kaplan ED, Pittman J, Elkind MS, Boden-Albala B, Wright CB, Rundek T, Stabler SP, Sacco RL.
Homocysteine Is Associated with Increased Vascular Morbidity and Mortality: The Northern Manhattan
Prospective Cohort. Neurology 2002;58(7), Supp.3: A98.
45. Boden-Albala B, Sacco RL, Pittman J, Elkind MS, Rundek T, Berglund L. The Relationship between High
Density Lipoprotein and Vascular Outcomes in a Multi-Ethnic Community: The Northern Manhattan
Prospective Cohort Study. Neurology 2002;58(7), Supp.3: A97.
46. Elkind MS, Pittman J, Boden-Albala B, Rundek T, Sacco RL. Moderate Alcohol Consumption Reduces
Risk of Ischemic Stroke and Death: The Northern Manhattan Prospective Cohort Study. Neurology
2002;58(7), Supp.3: A119.
47. Elkind MS, Sciacca RR, Boden-Albala B, Rundek T, Homma S, Di Tullio MR. Leukocyte Count Is
Associated with Aortic Arch Plaque Thickness: The Aortic Plaque and Risk of Ischemic Stroke Study
(APRIS). Neurology 2002;58(7), Supp.3: A279.
48. Rundek T, Elkind MS, Pittman J, Wright CB, Kaplan ED, Suk S-H, Boden-Albala B, Sacco RL. Carotid
artery diameter and stiffness varies in a population of elderly women and men: The Northern Manhattan
Stroke Study. Stroke 2002, 1(33):P46.
49. Boden-Albala B, Evans SK, Cheng J, Rundek T, Elkind MS, Santiago MM, Sacco RL. Social conditions
and outcomes after stroke: Findings from the Northern Manhattan Stroke Study. Stroke 2002, 1(33): 56.
50. Marshall RS, Fitzsimmons BF, Lazar RM, Rundek T. Stroke Subtype in hemodynamic failure. Stroke
2002, 1(33):P48.
51. Kaplan ED, Elkind MS, Rundek T, Wright CB, Boden-Albala B, Sacco RL. Blood levels of vitamin B12
and folate are associated with carotid artery plaque thickness: The Norther Manhattan Stroke Study. Stroke
2002, 1(33):P157.
52. Rundek T, Pittman J, Trocio S, Elkind MS, Boden-Albala B, Sacco RL. Carotid artery distensibility in a
multi-ethnic community: A reliability Study. Cerebrovasc Dis 2001; 11(suppl 3):1-47:18.
53. Elkind MS, Cheng JF, Boden-Albala B, Gaspard G, Rundek T Chen HJ, Rabbani L, Sacco RL. Tumor
necrosis factor receptor levels are associated with carotid atherosclerosis in a multiethnic population.
Neurology 2001;56 (Suppl 3):A287.
----------------------------------------------------------------------------------------------------------------------------- -------------------Tatjana Rundek, Curriculum Vitae_09
10 of 17
54. Kaplan ED, Chen JF, Boden-Albala B, Rundek T, Elkind MS, Sacco RL. Homocysteine Is associated with
carotid plaque thickness: The Northern Manhattan Stroke Study. Neurology 2001;56 (Suppl 3):A86.
55. Elkind MS, Cheng JF, Rundek T, Boden-Albala B, Sacco RL. White blood cell count predicts outcome
after stroke: The Northern Manhattan Stroke Study. Annals of Neurology 2001;50:S73.
56. Tamis-Holland JE, Boden-Albala B, Cheng J, Rundek T, Sacco RL. Sex differences in the presentation
and outcome of stroke patients. A gender analysis of the Northern Manhattan stroke Study. Circulation
2001, vol.104 No 17 (suppl II), 2508.
57. Rundek T, Elkind MS, Boden-Albala B, Humphries SE, Sacco RL. The association of carotid artery
intima-media thickness and allelic variants of stromyelysin-1, interlukin-6 and hepatic lipase genes: A pilot
study from the Northern Manhattan Stroke Study. Stroke 2001;32:336.
58. Nielsen K, Phillips SJ, Rundek T; for the GAIN Americas Investigators. Helthcare resource utilization in
the 3 months after acute stroke: A report on 1604 patients from the Glycine Antagonist in Neuroprotection
(GAIN) Americas Trial. Stroke 2001;32:380.
59. Marshall RS, Sproule DS, Rundek T, Futzsimmons BF, Sia RM, Lazar RM. Impaired cerebral
vasoreactivity correlates with recent symptomaticity in severe carotid artery disease. Stroke 2001;32:350.
60. Boden-Albala B, Evers SK, Rundek T, Elkind MS, Cheng JF, Sacco RL. Blood pressure status one year
post-stroke: Findings from the Northern Manhattan Stroke Study. Stroke 2001;32:322.
61. Labovitz D, Rundek T, Benson R, Sacco RL. 30-day case fatality in a multi-ethnic, population based
incident stroke cohort in northern Manhattan. Stroke 2000;31:2793.
62. Lennihan L, Boden-Albala B, Rundek T, Lin I-F, Paik MC, Sacco RL. Predictors of 6-month functional
outcome after stroke: The Northern Manhattan Stroke Study. Stroke 2000;17:83.
63. Rundek T, Mast H, Hartmann A, Lin I-F, Boden-Albala B, Sacco RL. Predictors of nursing home
placement and use of rehabilitation facilities after acute care hospitalization for ischemic stroke: Northern
Manhattan Stroke Study. Cerebrovasc Dis 1999; (1): 1-128; 114.
64. Rundek T, Di Tullio MR, Fard AK, Sciacca RR, Titova IV, Mohr JP, Homma S, Sacco RL. Association
between large arch atheromas and cerebral microemboli in elderly stroke patients. Stroke 1999; 1 (30): 238.
65. Rundek T, Elkind MS, Chen X, B.Boden-Alabala, Paik MC, Sacco RL. Increased early stroke recurrence
among patients with extracranial and intracranial atherosclerosis: The Northern Manhattan Stroke Study.
Neurology 1998; 4 (50, suppl 4): A75: S09.001.
66. Rundek T, Chen X, Hartman A, Gan R, Mast H, Sacco RL. Stroke syndrome as a predictor of nursing
home placement: The Northern Manhattan Stroke Study. 23rd Interantional Joint Conference on Stroke and
Cerebral Circulation, American Heart Association, Orlando, FL, 1998: p111.
67. Rundek T, Boden-Alabala B, DeRosa JT, Lennihan L, Chen X, Sacco RL. Functional outcome 6 months
after ischemic stroke: The influence of discharge destination after acute care hospitalization. 123rd Annual
Meeting of the American Neurological Association, Montreal, Canada, 1998; T205: 79-80.
68. Rundek T, Chen X, Steiner MM, Gan R, Roberts JK, Elkind MS, Boden-Albala B, Kargman DE, Sacco
RL. Predictors of 1-year stroke recurrence: The Northern Manhattan Stroke Study. Cerebrovasc Dis 1997; 7
(suppl 4): p.68, epi 10.
69. Steiner MM, Chen X, Rundek T, Gan R, Boden-Albala B, Mendoza LM, Homma S, Di Tullio MR, Sacco
RL. Neurologic findings in ischemic stroke patients with patent foramen ovale: The Northern Manhattan
Stroke Study. Cerebrovasc Dis 1997; 7 (suppl 4): p.35, cli 37.
70. Steiner MM, Rundek T, Chen X, Gan R, Boden-Albala B, Sacco RL. The impact of ischemic stroke on
quality of life: Northern Manhattan Stroke Study. Europ J Neurol 1997; 4(suppl1): S26
71. Rundek T, Stambuk N, Brinar V, Rudolf M, Rabatic S, Svoboda Beusan I, Mazuran R, Mauricus
Dellamarina B, Martinic R, Pokric B. Selective modulation of the immune response - applications in
clinical neurology. 11th International Conference on Mathematical and Computer Modelling and Scientific
Computing, Georgetown University Conference Center, Washington, DC, 1997.
72. Demarin V, Rundek T. Clinical relevance of cerebral embli detection in patients with nonvalvular atrial
fibrillation and prosthetic cardiac valves. Neurology 1997; 48(3): p03.002.
73. Rundek T, Demarin V, Vukovic V. TCD detection of cerebral emboli in patients with nonvalvular atrial
fibrillation: A 1-year follow-up survey. Cerebrovasc Dis 1996; (suppl 3)1-74: 259.
74. Demarin V, Rundek T, Miletic B. Prevalence of cerebral emboli in patients with carotid artery disease.
Cerebrovasc Dis 1996; (suppl 3)1-74: 243.
75. Podobnik S, Demarin V, Rundek T, Vargek V, Huzjan-Lovrencic A. Impact of risk factors on the
----------------------------------------------------------------------------------------------------------------------------- -------------------Tatjana Rundek, Curriculum Vitae_09
11 of 17
morphology of carotid artery plaques and stroke. Cerebrovasc Dis 1996; (suppl 3)1-74: 189.
76. Vargek V,, Demarin V, Podobnik S, Rundek T. The incidence of MCA occlusion in patients with acute
ischemic stroke. Cerebrovasc Dis 1996; (suppl 3)1-74: 164.
77. Demarin V, Huzjan-Lovrencic A, Podobnik S, Rundek T. The validity and pitfalls of TCCD in the
evaluation of intracranial pathology. Cerebrovasc Dis 1996; (suppl 3)1-74: 50.
78. Rundek T, Demarin V, Huzjan-Lovrencic A, Podobnik-Sarkanji S, Vukovic V. Detection of intracranial
emboli signals in patients with carotid and cardiac disease. 1996. Cerebral Hemodynamics and Embolism
Symposium, Jan 21-24. 1996., Dallas, Texas, USA.
79. Rundek T. Extracranial Color Doppler-applications and pitfalls. Proceedings of 36th International
Neuropsychiatric Symposium, Pula, June 1996, Neurol Crat 1996,(45)2: 47-48.
80. Demarin V, Rundek T, Podobnik S. Cerebral emboli detection in patients with nonvalvular atrial
fibrillation: Is it clinically relevant? Cerebrovasc Dis 1995; (suppl 2)1-192: 763.
81. Ivekovic R, Rundek T, Demarin V. Transbulbar orbital Color Doppler Imaging. Proceedings of 35th
International Neuropsychiatric Symposium, Pula, June 1995.
82. Rundek T, Demarin V, Huzjan-Lovrencic A, Podobnik-Sarkanji S. Transcranial Doppler and cerebral
vasoreactivity testing in patients with dementia. Proceedings of 35th International Neuropsychiatric
Symposium, Pula, June 1995.
83. Demarin V, Rundek T, Podobnik S. Changes of cerebral hemodynamics and serum 5-HT during migraine
attack. European Neurology Conference, Sept. 1995, Marselle, France.
84. Rundek T, Demarin V, Huzjan-Lovrencic A. Does vascular dementia differ from dementia of Alzheimer’s
type?: Cerebral vasoreactivity study and 5 years of follow up survey. European Neurology Conference,
Sept. 1995, Marselle, France.
85. Rundek T, Demarin V, Podobnik-Sarkanji S. Prevalence of intracranial emboli signals in patients with
carotid and cardiac disease, Neurosonology 95, Sept. 1995, Salzburg, Austria.
86. Demarin V, Rundek T, Huzjan-Lovrencic A, Podobnik-Sarkanji S. The accuracy of Transcranial Color
Coded Doppler in the evaluation of cerebral AV-malformations. Neurosonology 95, Sept. 1995, Salzburg,
Austria.
87. Rundek T, Demarin V, Podobnik-Sarkanji S. Prevalence of intracranial embolic signals in patients with
carotid and cardiac disease. J Neuroimag 1995, 5: 68.
88. Rundek T, Demarin V. Cerebral vasoreactive response (CVR) in patients with multi-infarct dementia
(MID), dementia of Alzheimer’s type (DAT) and dementia in Parkinson’s disease (PDP). Proceedings of
the International Symposium on Dementia in Parkinson’s disease, Jerusalem, Israel, 20-24.3.1994: 33.
89. Demarin V, Rundek T, Runjic D, Huzjan-Lovrencic A, Podobnik-Sarkanji S. Emboli detection by
Transcranial Doppler (TCD) in patients with carotid and cardiac disease. Proceedings of Third European
Stroke Conference, Stockholm, 26-28.5.1994, Cerebrovascular Dis 1994; 4: 244.
90. Podobnik-Sarkanji S, Demarin V, Rundek T. The morphology of carotid artery plaques in correlation with
risk factors. Proceedings of 34th International Neuropsychiatric Symposium, Pula 1.-4.6.1994: 31.
91. Rundek T, Demarin V, Runjic D, Huzjan-Lovrencic A, Podobnik-Sarkanji S. Prevalence of intracranial
emboli signals in patients with carotid and cardiac disease. Proceedings of 34th International
Neuropsychiatric Symposium, Pula 1.-4.6.1994: 34.
92. Demarin V, Rundek T, Huzjan-Lovrencic A. Transcranial Doppler in migraine. Proceedings of 34th
International Neuropsychiatric Symposium, Pula 1.-4.6.1994: 35.
93. Demarin V, Rundek T. Assessment of cerebral vsoreactivity in patients with multi-infarct dementia and
dementia of Alzheimer’s type. Fourth Meeting of the European Neurology Society, Barcelona, Spain,
25-29.6.1994, 21. J Neurol 1994; 241 (Suppl 1): s70.
94. Rundek T, Demarin V. Ultrasound emboli detection in patients with caroitd and cardiac disease. Fourth
Meeting of the European Neurology Society, Barcelona, Spain, 25-29.6.1994, J Neurol 1994; 241 (Suppl
1): s6.
95. Demarin V, Rundek T, Podobnik S, Huzjan-Lovrencic A. A correlation of cerebral hemodynamisc and
serum 5-hydoxytriptamine (5-HT) in migraine. 27th Danubine Symposium for Neurological Sciences,
Krems, Austria, Sept. 22-24, 1994.
96. Rundek T, Demarin V, Huzjan-Lovrencic A, Podobnik S. Multi-infarct dementia (MID), dementia of
Alzheimer’s type (DAT), and dementia in Parkinson’s disease (DPD): A study of cerebral vasoreactivity.
1st Croatian Neurological Conference, Split, 13-15.10. 1994.
----------------------------------------------------------------------------------------------------------------------------- -------------------Tatjana Rundek, Curriculum Vitae_09
12 of 17
97. Rundek T, Demarin V. A relevance of cerebral vasoreactivity testing in patients with multi-infarct
dementia (MID). 33th International Neuropsychiatric Symposium and Alps-Adria Postgraduate Course,
Pula, 10-12 June 1993: 47.
98. Rundek T, V Demarin. Color Doppler Flow Imaging (CDFI) in analysis of vessel narrowing in patients
with TIA. 2nd International Conference on Stroke, Geneve, Switzerland, May 12-15, 1993: 55.
99. Demarin V, Rundek T. Vasoreactivity testing in extracranial carotid artery disease. 2nd International
Conference on Stroke, Geneve, Switzerland, May 12-15, 1993: 45.
100.Dakic-Koretic D, Solter V, Zdunic D, Rundek T. Some biological distinction between affective and
schisophrenic disorders. Book of abstracts of 9th World Congress of Psychiatry, Rio De Janeiro,
6.-12.6.1993: 185.
101.Rundek T, Demarin V, Dakic-Koretic D. Correlation between mental deterioration and cerebral
vasoreactivity in patients with multi-infarct dementia. Book of abstracts of 9th World Congress of
Psychiatry, Rio De Janeiro, 6.-12.6.1993: 280.
102.Demarin V, Rundek T. A correlation of cerebral vasoreactivity (CVR) and 5-HT level in patients with
migraine. 15th World Congress of Neurology, Vancouver, BC, Canada, Sept. 5-10, 1993, The Canadian
Journal of Neurological Sciences 1993, 20: 61.
103.Rundek T, Demarin V. Cerebral vasoreactivity (CVR) in patients with multi-infarct dementia (MID) and
dementia of Alzheimer’s type. XVth World Congress of Neurology, Vancouver, BC, Canada, Sept. 5-10,
1993, The Canadian Journal of Neurological Sciences 1993, 20: 144.
104.Demarin V, Rundek T, Podobnik-Sarkanji S, Thaller N. A correaltion of 5-HT and cerebral vasoreactivity
in patients with migraine. Cephalalgia 1993;(spp 13): 69.
105.Demarin V, Rundek T. Transcranial Doppler and cerebral vsoreactivity testing in extracranial carotid
artery disease. European Journal of Ultrasound 1993;(1): 57.
106.Rundek T, Demarin V. Analysis of carotid and vertebral color doppler flow imaging in patients with TIA.
Book of abstracts of the 5th Meeting of Neurosonology Research Group of World Federation (WFN),
Toronto, Canada, 1.-3.9.1993: 9.
107.Demarin V, Rundek T. Cerebral vasoreactivity testing by TCD combined with acetazolamide test in
extracranial carotid artery disease. Book of abstracts of the 5th Meeting of Neurosonology Research Group
of World Federation, Toronto, Canada, 1.-3.9.1993:21.
108.Rundek T, Demarin V. Cerebral vasoreactivity in patients with multi-infarct dementia and dementia of
Alzheimer’s disease. Book of abstracts of 26th Danubine Symposium for neurological sciencies, Innsbruck,
30.8.-2.9.1993:16-17.
109.Demarin V, Rundek T. Transcranial Doppler combined with acetazolamide test in patients with TIA: A
reliable method for assessment of cerebral vasoreactivity. Book of abstracts of 26th Danubine Symposium
for neurological sciencies, Innsbruck, 30.8.-2.9.1993:17.
110.Rundek T, Demarin V. Cardioembolic stroke and carotid artery embolism in young adults. 3rd
International Symposium on Heart-brain Interactions, Bologna, 25.-26.10.1993:151.
111.Demarin V, Rundek T, Huzjan-Lovrencic A-Huzjan, Podobnik-Sarkanji S. A correlation of 5-HT and
cerebral vasoreactivity in patients with migraine. 1993 Meeting of the Eruopean Federation of Neurological
Societies (EFNS), Berlin, 8.-11.12.1993: 8.
112.Rundek T, Demarin V. Cerebral vasoreactive capacity in patients with extracranial carotid artery disease.
1993 Meeting of the Eruopean Federation of Neurological Societies (EFNS), Berlin, 8.-11.12.1993: 71.
113.Demarin V, Rundek T. Cerebral Vasoreactive Capacity Assessment by Transcranial Doppler in patients
with Ischemic Stroke. 36th Annual Convention of American Institute of Ultrasound in Medicine (AIUM),
San Diego, California, USA, March 8-11, 1992.
114.Demarin V, Rundek T. Transcranial Doppler (TCD) combined with acetazolamide (AZT) test in patients
with TIA: A reliable method for assessment of cerebral autoregulation reserve (CAR) in stroke prevention.
6th Symposium on Vascular Diagnosis, San Diego, California, USA, February 15-21, 1992: 366.
115.Podobnik-Sarkanji S, Thaller N, Demarin V, Rundek T, Martinic I. Transcranial Doppler assessment in
stroke patients with speech disorders. 32nd International Neuropsychiatric Symposium, Graz, Austria,
1992: 118.
116.Demarin V, Rundek T, Podobnik-Sarkanji S. A correlation between low level of plasma 5-HT and MG
with cerebral vasoreactivity in patients with migraine. Neurology 1992; 239 (supl.2): 43.
117.Rundek T, Demarin V, Podobnik-Sarkanji S, Thaller N. Carotid color Doppler flow imaging versus
----------------------------------------------------------------------------------------------------------------------------- -------------------Tatjana Rundek, Curriculum Vitae_09
13 of 17
duplex scanning in plaque characterization. J Nuroimag 1992; (2): 221.
118.Demarin V, Rundek T, Podobnik-Sarkanji S A correlation between low level of plasma 5-HT level and
Mg with cerebral vasoreactivity in patients with migraine, J Neurol 1992; 239: 43-44.
119.Demarin V, Rundek T, Podobnik-Sarkanji S. Assessment of cerebral autoregulation reserve (CAR) by
TCD in patients with TIA: A reliable method in stroke prevention. Second European Stroke Conference,
June 25-27,1992: 34.
120.Demarin V, Rundek T, Podobnik-Sarkanji S, Thaller N. Color Doppler Flow Imaging (CDFI) in
comparison with Duplex scanning in carotid artery disease. The 3rd Congress of Asian federation of
Societies for ultrasound in medicine and biology, Seoul, Korea 30.8.-3.9.1992: 57.
121.Demarin V, Rundek T, Podobnik-Sarkanji S. Assessment of cerebral vasoreactivity (CVR) by TCD in
patients with multi-infarct dementia (MID). Second World Congress of Stroke, Washington DC,
8-12.9.1992: 67.
122.Demarin V, Rundek T, Podobnik-Sarkanji S, Martinic I, Lukinac Lj, Kusic Z. Correlation between low
level of plasma 5-HT with cerebral vasoreactivity in patients with migraine. Congress of Migraine Trust,
London, UK, 7-11.9.1992: 15.
123.Demarin V, Vujic D, Podobnik-Sarkanji S, Rundek T. Dihydroergotoxine and low molecular dextrane in
acute ischemic stroke: A double blind multicentric study. Abstract book of 4th International Symposium on
Pharmacology of cerebral ischemia, Marburg, 1992: 107.
124.Demarin V, Podobnik-Sarkanji S, Rundek T, Thaller N. A correlation between cerebral vasoreactivity and
plasma level of 5-HT in patients with migraine. Abstracts of 25th Danube Symposium for Neurological
Sciencies, 25th Danube Symposium for Neurological Sciencies, Budapest, 1992: 63.
125.Rundek T, Koretic D, Demarin V. A measurment of cerebral blood flow (CBF) in middle cerebral artery
(MCA) by Transcranial Doppler in major depressive syndrome (MDS). Supplement to Biological
Psychiatry, A Journal of Psychiatric Research, World Federation of Societies of Biological Psychiatry, 5th
World Congress, Firenza, Italy, June 9-14, 1991, 29(11S): P-02-12.
126.Demarin V, Rundek T, Podobnik-Sarkanji S, Seric V. Transcranial Doppler (TCD) assessment of the
cerebral circulatory capacity (CAC) in patients with multi-infarct dementia (MID). Brain Dysfunction 1991,
4(1): 46.
127. Dordevic V, Cop-Blazic N, Demarin V, Rundek T, Petric N, Javornik N. Zagreb’s Non-smoking Program.
Libri oncologici, VIIIth National Conference of Oncologists, Zagreb, 9-11.5.1991: 29-9.
128.Cop-Blazic N, Dordevic V, Demarin V, Rundek T, N. Javornik. Prevenetion of smoking among younges.
Libri oncologici, VIIIth National Conference of Oncologists, Zagreb, 9-11.5.1991: 29-10.
129.Javornik N, Dordevic V, Cop-Blazic N, Rundek T. Smoking among students. Libri oncologici, VIIIth
National Conference of Oncologists, Zagreb, 9-11.5.1991: 29-11.
130.Demarin V, Rundek T. The assessment of cerebral autoregulatory capacity (CAC) in ischemic
hemodynamic stroke. Fourth Meeting of Neurosonology Research Group of the World Federation of
Neurology, Hiroshima, Japan, June 6-8, 1991 (S1-6): 94.
131.Demarin V, Rundek T, Podobnik-Sarkanji S, Seric V. Transcranial Doppler investigation of cerebral
autoregulatory capacity (CAC) in patients with multi-infarct dementia (MID). Proceedings of 2nd
International Symposium of Brain Dysfunction, Troina, Sicily, Italy, Sept. 23-26, 1991.
132.Dabic-Jeftic M, Mikula I, Saric A, Rundek T. Transcranial Doppler sonography and endogenous evoked
potentials (P300) mapping in drug addicts. 6th World Congress in Ultrasound, 3rd World Congress for
Sonographers, Copenhagen, Sept. 1-6, 1991: 8903.
133.Demarin V, Rundek T, Podobnik-Sarkanji S. Transcranial Doppler investigation (TCD) of cerebral
autoregulatory capacity (CAC) in patients with stroke. 6th World Congress in Ultrasound, 3rd World
Congress for Sonographers, Copenhagen, Sept. 1-6, 1991:3505.
134.Podobnik-Sarkanji S, Demarin V, Rundek T. Transcranial Doppler (TCD) performed at rest and during
mental activities in patirnts with concussion of the brain. 2nd Congress of PanEuropean Society of
Neurology, Laussane, 7-12.12.1991:137.
135.Demarin V, Rundek T. Transcranial Doppler (TCD) testing of cerebral autoregulatory capacity using
acetazolamide (AZT). 2nd Congress of PanEuropean Society of Neurology, Laussane, 7-12,12. 1991:185.
----------------------------------------------------------------------------------------------------------------------------- -------------------Tatjana Rundek, Curriculum Vitae_09
14 of 17
PROFESSIONAL
Funded Research Performed (include all grants received in the last five years, identifying the principal
investigator, and the amounts and dates of the awards):
Grant Title
Active
“Genetic Determinants of Subclinical Carotid Disease”,
University of Miami, FL
Role: PI (effort 30%)
“Northern Manhattan Study- Stroke Incidence and Risk
Factors in a Tri-Ethnic Region”, Columbia University
&University of Miami, NY (PI: Ralph L. Sacco)
Role: Coinvestigator (effort 30%)
“Family Study of Stroke Risk and Carotid Atherosclerosis”,
Columbia University, NY (PI: Ralph L. Sacco)
Role: Coinvestigator (effort 15%)
“INVEST – Infection Diseases and Stroke Risk”; Columbia
University, NY, (PI: Moise Deseveroux)
Role: Coinvestigator (effort 10%)
“Primary Hyperparathyroidism: Non-Classical
Manifestations”, Columbia University, NY (PI: Shonni
Silverberg)
Role: Coinvestigator (effort 10%)
“Clopidogrel versus Aspirin Carotid Ultrasound Stroke Study
(CASS)”, Columbia University, NY
Role: PI (currently 0%)
“MESA: Multi Ethnic Subslinical Artherosclerosis study”,
Columbia University, NY (PI: Steve Shea)
Role: Coinvestigator (currently 0%)
“Healthy Lifestyle and Prevention of Stroke”, the WHO
project “Health for All until 2010”, (Directors: Roman L.
Haberl, Munich, Germany; Kurt Niederkorn, Graz, Austria;
Vida Demarin, Zagreb, Croatia, Tatjana Rundek, FL &NY)
Role: Co-Director (effort 5%)
“A Multicenter, Randomized, Double-Blind
Placebo-Controlled Study to test the Safety and Efficacy of
Lipitor (atorvastatin) in Reducing the Progression of Carotid
IMT in Early Childhood SLE", The Atherosclerosis
Prevention in Pediatric Lupus Erythematosus (APPLE) Study
(PI: Laura E. Schanberg, Duke University Medical Center)
Role: Site Coinvestigator, (currently 0%)
Past
“The molecular mechanisms of RAGE antagonism on early
atherosclerosis in HGHL swine”, Columbia University, NY
(PI: Ann Marie Schmidt) Role: Coinvestigator, past
“The Effect of Atorvastatin on carotid plaque morphology
assessed by gray scale ultrasound densitometry analyses”,
Columbia University & University of Miami, NY
Role: PI, past
“A prospective multicenter clinical trial to establish dynamic
vascular analysis indices for patients with SAH”, Columbia
Year(s)
Funding Agency
01/01/0412/31/08
NIH/NIDCR
R01 NS 047655
$231,250 /y
NIH/NINDS
2 R01 NS 029993-11
$996,168 /y
02/01/0001/31/13
05/01/0204/30/08
04/15/014/16/11
7/01/0506/30/10
NIH/NINDS
1 R01 NS 40807
$592,794 /y
NIH/NIDCR
2R01 DE013094
$984,252 /y
NIH/NIDK
R01 DK 66329-01A2
$354,588/y
2005-08
Sanofi-Aventis BMS
$40,000 /y
01/14/99 –
02/14/09
NIH/NHLBI-HC
$203,504 /y
2000-10
WHO
$10,000 /y available
to TR
2004-08
NIH
NIAMS BAA-02
$150,000
2005-07
JDRF Center
Columbia University
$150,000
Pfizer, Inc
$65,000
2005-07
2005-07
New Health Sciences,
Inc.
----------------------------------------------------------------------------------------------------------------------------- -------------------Tatjana Rundek, Curriculum Vitae_09
15 of 17
University, NY ( PI: Neeraj Badjatia)
Role: Site Coinvestigator, past
“A prospective multicenter clinical trial to establish dynamic
vascular analysis indices for patients undergoing carotid artery
surgery”, Columbia University, NY ( PI: James McKinsey)
Role: Site Coinvestigator, past
“A prospective multicenter clinical trial to establish dynamic
vascular analysis indices for patients undergoing carotid artery
stenting”, Columbia University, NY ( PI: Issam Moussa)
Role: Site Coinvestigator, past
“Aortic, cardiovascular disease and silent brain infarcts”,
Columbia University, NY (PI: Marco R. Di Tulio)
Role: Coinvestigator, (currently 0%)
The ESCAPE Migraine trial
Role: Study PI (TCD monitoring), past
“The short-term effect of atorvastatin on carotid artery wall
elasticity : A B-mode ultrasound pilot study and evaluation of
correlation of wall elasticity changes with changes in
inflammatory biomarker Lp-PLA2”. Columbia University,
NY
Role: PI, past
“Imaging subclinical markers of atherosclerosis and risk of
stroke in women”, Columbia University, NY
Role: PI, past
“Carotid Distensibility and risk of stroke”, Columbia
University, NY
Role: PI, past
$50,000
2005-07
New Health Sciences,
Inc.
$50,000
2005-07
New Health Sciences,
Inc.
$50,000
2005-10
NINDS
R01 NS 36286
$245,000 /y
St. Jude Medical
$40,000
DiaDexus, Inc
$10,000
2006-07
2006-07
2001-06
2004-07
The Hazel K.
Goddess Fund
$195,000
2001-062004AIUM (American
Institute of Ultrasound
in Medicine)
$20,000
Editorial responsibilities:
Associated Editor of the professional journals:
Therapy (2006-)
Editorial board member of the professional journals:
Stroke (2004-)
The Journal of CardioMetabolic Syndrome (2005-)
Reviewer for the professional journals:
Stroke (2003-)
Neurology (2002-)
Neuroepidemiology (2003-)
Cerebrovascular Diseases (2005-)
Scandinavian Journal of Rheumatology (2006-)
Journal of Ultrasound in Medicine (2002-)
Atherosclerosis, Thrombosis, and Vascular Biology (2005-)
Circulation (2007-)
Journal of Cardiovascular Pharmacology (2007-)
Journal of American College of Cardiology (2008-)
International Journal of Stroke (2008-)
Professional and Honorary Organizations (member; officer; date):
President elect of the Neurosonology Community of Practice of the American Institute of Ultrasound
in Medicine (2009-)
----------------------------------------------------------------------------------------------------------------------------- -------------------Tatjana Rundek, Curriculum Vitae_09
16 of 17
Croatian Medical Association, Neurology Panel Delegate (1990-)
European Society of Neurosonology and Cerebral Hemodynamics, Member (1995-)
American Institute of Ultrasound in Medicine, TCD Delegate (1995-)
American Academy of Neurology, Member (1997-)
American Heart Association, Member (1998-)
European Federation of Neurological Societies, Neurology Panel Delegate (1998-)
Croatian-American Fulbright Association (President, 2000-)
Neurosonology Section of AIUM American Institute of Ultrasound in Medicine, Treasurer (2004-)
Panel delegate of the International Committee for Standardization of the IMT (Intima-media
thickness) ultrasound technique; Mannheim, Germany; and Brussels, Belgium, (2004-)
Panel Delegate of the 5 Country Study on Epidemiology of Atherosclerosis; Paris, France (2006-)
Honors and Awards:
Humbolt Award, Germany, 1995
George Soros Award in Teaching (Society of Eastern and Western Europe Medical Associations),
Austria, 1996
Fulbright Award, Columbia University, New York, NY, 1997
President and the UN Delegate of the International Fulbright Scholars in Year 2000
The Hazel K. Goddess Award for Stroke Research in Women, New York, NY, 2001
The Gilbert Baum Award for the best clinical ultrasound application, 2004
Nassau Women Physicians Foundation Award for Stroke Research in Women; Long Island, NY, 2006
Post-Doctoral Fellowships:
Stroke Fellow
Stroke Fellow
University of Ulm, Germany
Columbia-Presbyterian Medical Center, NY
Columbia University, New York, NY
1995-96
1998-2000
Consultative Services
Consultant for New Health Sciences, Inc (TCD monitoring; 2004-)
Speaker and consultant for the Sanofi-Aventis/BMS partnership (clopidogrel; 2005-)
Consultant for Pfizer, Inc. (atorvastatin; 2005-)
Consultant for SonoSite, Inc (Carotid IMT; 2004-08)
Consultant for St. Jude Medical (TCD monitoring in PFO; 2006-08)
TEACHING
Teaching Awards Received:
George Soros Award in Teaching (Board of the Society of Eastern and Western Europe Medical
Associations), Austria, 1996
-selected from 500 delegates from the eastern European countries for best medical teaching
SERVICE
University Committee and Administrative Responsibilities [with inclusive dates]
APT Committee Promotion (Neurology, UM), 2007Faculty Search Committee (Neurology, UM), 2007Neuroimaging Committee (Neurology, UM), 2008Strategic Planning Administrative Pillar (Neurology, UM), 2008CME Grand Rounds (UM Neurology), 2009----------------------------------------------------------------------------------------------------------------------------- -------------------Tatjana Rundek, Curriculum Vitae_09
17 of 17